niraparib - Robuta Search

https://www.healthday.com/healthpro-news/cancer/niraparib-plus-aap-improves-survival-in-mcspc-with-hrr-gene-alterations Niraparib Plus AAP Ups Survival in mCSPC With HRR Gene Alterations For patients with metastatic castration-sensitive prostate cancer with homologous recombination repair gene alterations, the addition of niraparib to... niraparib plus aap ups survival https://www.gsk.com/en-gb/media/press-releases/gsk-provides-an-update-on-zejula-niraparib-us-prescribing-information/ GSK provides an update on Zejula (niraparib) US prescribing information | GSK Zejula is an oral, once-daily PARP inhibitor currently being evaluated in multiple pivotal trials. an update gsk provides zejula niraparib https://www.jnj.com/innovativemedicine/us/janssen-presents-updated-data-demonstrating-improved-outcomes-use-niraparib-combination-abiraterone Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in... https://www.jnj.com/media-center/press-releases/janssen-presents-new-data-demonstrating-the-combination-of-niraparib-and-abiraterone-acetate-plus-prednisone-significantly-improved-radiographic-progression-free-survival-as-a-first-line-therapy-in-patients-with-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus... Jul 17, 2025 - Initial results from Phase 3 MAGNITUDE study, to be featured in a late-breaking oral presentation at ASCO GU, highlight subset of patients with mCRPC most... https://www.nice.org.uk/guidance/ta673 Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after... This guidance has been updated and replaced by NICE's technology appraisal guidance 1129 https://www.cancer.gov/about-cancer/treatment/drugs/niraparib-tosylate-monohydrate-and-abiraterone-acetate Niraparib Tosylate Monohydrate and Abiraterone Acetate - NCI This page contains brief information about niraparib tosylate monohydrate and abiraterone acetate and a collection of links to more information about the use... niraparib tosylate abiraterone acetate monohydrate nci https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-stereotactic-radiotherapy-and-niraparib-for-ovarian-cancer-soprano Cancer Research UK | A trial looking at stereotactic radiotherapy and niraparib for ovarian cancer... This trial is looking at stereotactic radiotherapy by itself and followed by niraparib for ovarian cancer that has started to grow again. cancer research uk https://www.mayo.edu/research/clinical-trials/cls-20491028 A Study To Evaluate Niraparib And TSR-042 In Patients With Germline Or Somatic BRCA1/2 And... Learn more about services at Mayo Clinic. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-niraparib-ovarian-cancer-change-brca-gene-responded-platinum-chemotherapy-nova A trial of niraparib for ovarian cancer that has come back after platinum chemotherapy (NOVA) This trial looked at a drug called niraparib for ovarian cancer, fallopian tube cancer or primary peritoneal cancer. https://www.globenewswire.com/news-release/2017/03/13/935083/21179/en/Tesaro-Announces-Presentation-of-Niraparib-Phase-3-ENGOT-OV16-NOVA-Trial-Secondary-Endpoint-Results-During-SGO.html Tesaro Announces Presentation of Niraparib Phase 3 NATIONAL HARBOR, Md., March 13, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the... tesaro announces presentation niraparib phase https://www.cancerresearchuk.org/about-cancer/treatment/drugs/niraparib Niraparib (Zejula) | Cancer information | Cancer Research UK Niraparib is a type of targeted cancer drug. It is a treatment for some types of ovarian, fallopian tube or primary peritoneal cancers. Find out more about the... cancer information niraparib zejula research uk https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-brca-mutated-metastatic-castration FDA approves niraparib and abiraterone acetate plus prednisone for BRCA-mutated metastatic... FDA approves niraparib and abiraterone acetate plus prednisone for BRCA-mutated metastatic castration-resistant prostate cancer abiraterone acetate https://niraparix.com/ Niraparix (Niraparib) | Beacon Pharmaceuticals PLC Beacon Pharmaceuticals PLC beacon pharmaceuticals niraparib plc https://zejulahcp.com/ Ovarian Cancer Treatment | ZEJULA (niraparib) for HCPs Learn about ZEJULA (niraparib), a once-daily oral PARP inhibitor for adults with HRD-positive aOC. Find more information about this maintenance option. ovarian cancer treatment zejula niraparib hcps